West Pharmaceutical Services, Inc.
General ticker "WST" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $18.7B (TTM average)
West Pharmaceutical Services, Inc. follows the US Stock Market performance with the rate: 21.6%.
Estimated limits based on current volatility of 1.6%: low 276.24$, high 285.39$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (irregularly): last record date 2025-11-12, amount 0.22$ (Y0.08%)
- Total employees count: 10600 as of 2024
- US accounted for 42.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Manufacturing disruptions, Currency fluctuations, Economic downturns and volatility, Regulatory and compliance, Liquidity and credit risks
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [255.58$, 366.27$]
- 2025-12-31 to 2026-12-31 estimated range: [267.46$, 382.54$]
Financial Metrics affecting the WST estimates:
- Negative: with PPE of 48.9 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 19.84 > 18.64
- Positive: Return on assets ratio (scaled to [-100,100]) of 11.60 > 6.04
- Positive: Inventory ratio change, % of -1.64 <= -0.75
- Positive: Shareholder equity ratio, % of 73.62 > 63.39
Short-term WST quotes
Long-term WST plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,860.10MM | $2,918.40MM | $2,872.20MM |
| Operating Expenses | $2,126.10MM | $2,242.40MM | $2,302.30MM |
| Operating Income | $734.00MM | $676.00MM | $569.90MM |
| Non-Operating Income | $-54.10MM | $22.00MM | $15.60MM |
| Interest Expense | $7.90MM | $9.00MM | $3.00MM |
| R&D Expense | $58.50MM | $68.40MM | $69.10MM |
| Income(Loss) | $679.90MM | $698.00MM | $585.50MM |
| Taxes | $114.70MM | $122.30MM | $107.50MM |
| Other Income(Loss) | $20.70MM | $17.70MM | $14.70MM |
| Profit(Loss)* | $585.90MM | $593.40MM | $492.70MM |
| Stockholders Equity | $2,684.90MM | $2,881.00MM | $2,682.30MM |
| Inventory | $414.80MM | $434.70MM | $377.00MM |
| Assets | $3,616.80MM | $3,829.50MM | $3,643.40MM |
| Operating Cash Flow | $724.00MM | $776.50MM | $653.40MM |
| Capital expenditure | $284.60MM | $362.00MM | $377.00MM |
| Investing Cash Flow | $-288.20MM | $-368.70MM | $-378.70MM |
| Financing Cash Flow | $-293.60MM | $-459.60MM | $-622.60MM |
| Earnings Per Share** | $7.87 | $7.99 | $6.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.